Filter Results:
(182)
Show Results For
- All HBS Web
(182)
- News (50)
- Research (89)
- Events (2)
- Multimedia (3)
- Faculty Publications (47)
Show Results For
- All HBS Web
(182)
- News (50)
- Research (89)
- Events (2)
- Multimedia (3)
- Faculty Publications (47)
Page 1 of 182
Results →
- Research Summary
Biological Basis of Economic Behavior
Terry Burnham's research focuses on understanding human behavior, and economic behavior in particular, in the context of humans as evolved animals.
This research aims to reconcile two competing views within economics. The mainstream economic view is that economic... View Details
- December 2006 (Revised December 2007)
- Case
The Convention on Biological Diversity: Engaging the Private Sector
By: David E. Bell and Mary L. Shelman
The Convention on Biological Diversity (CBD) was a U.N. treaty that by 2006 had been signed by virtually every country in the world except for the United States. The treaty established three main goals: the conservation of biological diversity, the sustainable use of... View Details
Keywords: Agribusiness; Private Sector; Business and Community Relations; Business and Government Relations; Genetics; Environmental Sustainability
Bell, David E., and Mary L. Shelman. "The Convention on Biological Diversity: Engaging the Private Sector." Harvard Business School Case 507-020, December 2006. (Revised December 2007.)
- October 2015
- Article
Hormones and Ethics: Understanding the Biological Basis of Unethical Conduct
By: Jooa Julie Lee, Francesca Gino, Ellie Shuo Jin, Leslie K. Rice and Robert A. Josephs
Globally, fraud has been rising sharply over the last decade, with current estimates placing financial losses at greater than $3.7 trillion dollars annually. Unfortunately, fraud prevention has been stymied by lack of a clear and comprehensive understanding of its... View Details
Lee, Jooa Julie, Francesca Gino, Ellie Shuo Jin, Leslie K. Rice, and Robert A. Josephs. "Hormones and Ethics: Understanding the Biological Basis of Unethical Conduct." Journal of Experimental Psychology: General 144, no. 5 (October 2015): 891–897.
- Article
A Collective Biological Processing Algorithm for EKG Signals
By: Mike Horia Teodorescu
We establish and explore an analogy between hunting by packs of agents and signal processing. We present a version of adaptive ‘Hunting Swarm’ algorithm (HSA), apply it to EKG signals, and investigate the influence of the model parameters on the filtering of stationary... View Details
Teodorescu, Mike Horia. "A Collective Biological Processing Algorithm for EKG Signals." Proceedings of the International Conference on Bio-inspired Systems and Signal Processing 4th (2011): 413–420. (IEEE BIOSIGNALS 2011.)
- Awards
Selected to attend Seminar on Public Policy and Biological Threats
Selected to attend the 2006 Institute on Global Conflict and Cooperation Seminar on Public Policy and Biological Threats. View Details
- March 2011 (Revised June 2012)
- Case
Office of Technology Transfer - Shanghai Institutes for Biological Sciences
By: Willy Shih, Sen Chai, Kamen Bliznashki and Courtney Hyland
Gordon Zong is trying to teach Chinese universities and research institutes how to do effective technology transfer and IP licensing, but he is trying to do it in an environment with weak property rights and an underdeveloped support infrastructure. As the managing... View Details
Keywords: Multinational Firms and Management; Patents; Knowledge Management; Law Enforcement; Business and Government Relations; Research and Development; Biotechnology Industry; Pharmaceutical Industry; China
Shih, Willy, Sen Chai, Kamen Bliznashki, and Courtney Hyland. "Office of Technology Transfer - Shanghai Institutes for Biological Sciences." Harvard Business School Case 611-057, March 2011. (Revised June 2012.)
- Research Summary
Interaction of biological and psychological drivers of obesity
With a multi-disciplinary team of researchers in nutrition, microbiology, and epidemiology, we received a large grant to fund the Institute for Cardio-Metabolism and Nutrition (ICAN), a major initiative to promote research on obesity and... View Details
- 18 Nov 2014
- News
Giving women more control over their biological clocks
Reproductive technology pioneer Christy Jones (MBA 2004) founded Extend Fertility in 2004 to enable women to freeze their eggs and then utilize them when the time is right. (Published November 2014) View Details
- April 2011
- Teaching Note
Office of Technology Transfer - Shanghai Institutes for Biological Sciences (TN)
By: Willy Shih and Sen Chai
Teaching Note for 611057. View Details
- November 2009 (Revised November 2010)
- Case
SIPEF: Biological Assets at Fair Value under IAS 41
This case examines fair value accounting under lAS 41 for a European-listed agricultural firm. Students identify the firm's core operations, distinguishing the IFRS treatment for three distinct assets: land, agricultural assets that reside on the land, and inventory... View Details
Keywords: Business Earnings; Fair Value Accounting; Financial Reporting; International Accounting; Standards; Valuation; Agriculture and Agribusiness Industry; Europe
Riedl, Edward J., and Kristin Elaine Meyer. "SIPEF: Biological Assets at Fair Value under IAS 41." Harvard Business School Case 110-026, November 2009. (Revised November 2010.)
- March 2019
- Article
Crime and Violence: Desensitization in Victims to Watching Criminal Events
By: Rafael Di Tella, Lucia Freira, Ramiro H. Gálvez, Ernesto Schargrodsky, Diego Shalom and Mariano Sigman
We study desensitization to crime in a lab experiment by showing footage of criminal acts to a group of subjects, some of whom have been previously victimized. We measure biological markers of stress and behavioral indices of cognitive control before and after treated... View Details
Keywords: Crime; Biological Markers; Experiment; Victimization; Desensitization; Crime and Corruption; Behavior
Di Tella, Rafael, Lucia Freira, Ramiro H. Gálvez, Ernesto Schargrodsky, Diego Shalom, and Mariano Sigman. "Crime and Violence: Desensitization in Victims to Watching Criminal Events." Journal of Economic Behavior & Organization 159 (March 2019): 613–625.
- 2017
- Working Paper
Crime and Violence: Desensitization in Victims to Watching Criminal Events
By: Rafael Di Tella, Lucía Freira, Ramiro H. Gálvez, Ernesto Schargrodsky, Diego Shalom and Mariano Sigman
We study desensitization to crime in a lab experiment by showing footage of criminal acts to a group of subjects, some of whom have been previously victimized. We measure biological markers of stress and behavioral indices of cognitive control before and after treated... View Details
Keywords: Crime; Biological Markers; Experiment; Victimization; Desensitization; Crime and Corruption; Perspective; Attitudes; Behavior
Di Tella, Rafael, Lucía Freira, Ramiro H. Gálvez, Ernesto Schargrodsky, Diego Shalom, and Mariano Sigman. "Crime and Violence: Desensitization in Victims to Watching Criminal Events." Harvard Business School Working Paper, No. 18-039, October 2017.
- August 2018
- Article
The Impact of the Entry of Biosimilars: Evidence from Europe
By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby... View Details
Keywords: Health Care; Biosimilars; Biologics; Pharmaceutical Competition; Healthcare Spending; Innovation; Health Care and Treatment; Spending; Market Entry and Exit; Competition; Innovation and Invention; Pharmaceutical Industry; United States; Europe
Scott Morton, Fiona M., Ariel Dora Stern, and Scott Stern. "The Impact of the Entry of Biosimilars: Evidence from Europe." Review of Industrial Organization 53, no. 1 (August 2018): 173–210.
- July 2012 (Revised February 2013)
- Case
Société Internationale de Plantations et de Finance (SIPEF)
By: David Hawkins
Management of a company with extensive palm oil tree plantations questions the usefulness to management and investors of IAS41's requirement to value palm oil trees at their fair value. View Details
Keywords: Financial Accounting; International Financial Reporting Standards; International Accounting Standards; Biological Asset Accounting; IAS41; Historical Cost; Equity Valuation; Financial Ratios; Plant-Based Agribusiness; International Accounting; Valuation; Financial Reporting; Fair Value Accounting; Equity; Agriculture and Agribusiness Industry
Hawkins, David. "Société Internationale de Plantations et de Finance (SIPEF)." Harvard Business School Case 113-027, July 2012. (Revised February 2013.)
- January 2020
- Case
Celata Bioinnovations
By: John R. Wells and Benjamin Weinstock
In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process.... View Details
Keywords: Drug Development; Drug Discovery; Drug Trials; Pharmaceutical Companies; Pharmaceutical Company; Pharmaceuticals; Therapeutics; Biologics; Biotech; Biotechnology; Biopharmacy Company; Biochemistry; Technology Commercialization; Technology Companies; Drug Testing; Startup; Start-up; Startups; Start-ups; Startup Financing; Strategic Decision Making; Strategic Decisions; Strategic Evolution; FDA; Food And Drug Administration; Clinical Trials; Disease Management; Market Attractiveness; Market Entry; Market Opportunities; Health Disorders; Technological Innovation; Information Technology; Commercialization; Business Startups; Finance; Decision Making; Strategy; Market Entry and Exit; Opportunities; Pharmaceutical Industry; Biotechnology Industry
Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
- 04 Apr 2016
- HBS Seminar
Ariel Stern, Harvard Business School
- 09 Jul 2019
- Blog Post
Solving the Complexities of the Biotechnology Industry
Biotechnology is a complex industry which combines applied science & engineering and applied business practices with life science. It is the most multi-faceted industry segment there is because it is ultimately focused on the most complex open system: The human... View Details
- January 2007 (Revised January 2007)
- Background Note
Note on the U.S. Food and Drug Administration
By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details
Keywords: Health; Governance Compliance; Policy; Product Development; Government and Politics; Pharmaceutical Industry; Medical Devices and Supplies Industry; Biotechnology Industry; Public Administration Industry; United States
Higgins, Robert F., Richard G. Hamermesh, and Virginia Fuller. "Note on the U.S. Food and Drug Administration." Harvard Business School Background Note 807-050, January 2007. (Revised January 2007.)
- 01 Mar 2013
- News